Global Biologics Outsourcing Formulation Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biologics Outsourcing Formulation Services Market Research Report 2024
According to MRAResearch’s new survey, global Biologics Outsourcing Formulation Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the Biologics Outsourcing Formulation Services industry include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biologics Outsourcing Formulation Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biologics Outsourcing Formulation Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biologics Outsourcing Formulation Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Key companies engaged in the Biologics Outsourcing Formulation Services industry include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biologics Outsourcing Formulation Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biologics Outsourcing Formulation Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Segment by Application
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biologics Outsourcing Formulation Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source